Literature DB >> 12700609

DiGeorge subtypes of nonsyndromic conotruncal defects: evidence against a major role of TBX1 gene.

Emanuela Conti1, Nicoletta Grifone, Anna Sarkozy, Caterina Tandoi, Bruno Marino, Maria Cristina Digilio, Rita Mingarelli, Antonio Pizzuti, Bruno Dallapiccola.   

Abstract

The role of the 22q11 region genes, and among them TBX1, in nonsyndromic conotruncal defects (CTDs) is still unclear. Mice hemizygous at the Tbx1 locus show a remarkable incidence of heart outflow tract anomalies, of the same type commonly found in DiGeorge/Velo-cardio-facial syndrome (DGS/VCFS). Mutation analysis of the TBX1 gene in isolated, nonsyndromic CTDs has not demonstrated any functional pathogenetic variation so far. We screened the TBX1 gene in 41 patients affected by nonsyndromic CTDs of the DGS/VCFS subtype, principally "atypical" tetralogy of Fallot. Besides a few polymorphisms, we did not find any pathogenetic variation. These results do not support a major role of the TBX1 gene as responsible for human nonsyndromic CTDs.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12700609     DOI: 10.1038/sj.ejhg.5200956

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  18 in total

1.  Mutation Analysis of TBX1 in Children with Conotruncal Heart Anomalies.

Authors:  Teena Koshy; Vettriselvi Venkatesan; Kalpana Gowrishankar; Venkatachalam Perumal; Shruthi Mohan; Solomon Franklin Durairaj Paul
Journal:  Indian J Pediatr       Date:  2015-12-04       Impact factor: 1.967

2.  Human TBX1 missense mutations cause gain of function resulting in the same phenotype as 22q11.2 deletions.

Authors:  Christiane Zweier; Heinrich Sticht; Inci Aydin-Yaylagül; Christine E Campbell; Anita Rauch
Journal:  Am J Hum Genet       Date:  2007-01-18       Impact factor: 11.025

3.  A mouse splice-site mutant and individuals with atypical chromosome 22q11.2 deletions demonstrate the crucial role for crkl in craniofacial and pharyngeal development.

Authors:  Kerry A Miller; Tiong Y Tan; Megan F Welfare; Susan M White; Zornitza Stark; Ravi Savarirayan; Trent Burgess; Andrew A Heggie; Georgina Caruana; John F Bertram; John F Bateman; Peter G Farlie
Journal:  Mol Syndromol       Date:  2014-11-08

4.  Investigation of TBX1 gene deletion in Iranian children with 22q11.2 deletion syndrome: correlation with conotruncal heart defects.

Authors:  Hamid Ganji; Mansoor Salehi; Maryam Sedghi; Hossein Abdali; Nayereh Nouri; Leyli Sadri; Majid Hosseinzadeh; Bahareh Vakili; Mahdi Lotfi
Journal:  Heart Asia       Date:  2013-09-12

5.  Polymorphisms of VEGF, TGFβ1, TGFβR2 and conotruncal heart defects in a Chinese population.

Authors:  Enshi Wang; Zhenhua Wang; Shenghua Liu; Haiyong Gu; Dingxu Gong; Kun Hua; Yu Nie; Jue Wang; Haoran Wang; Jie Gong; YuJian Zhang; Hui Zhang; Ruiping Liu; Shengshou Hu; Hao Zhang
Journal:  Mol Biol Rep       Date:  2014-01-18       Impact factor: 2.316

6.  Genotype and cardiovascular phenotype correlations with TBX1 in 1,022 velo-cardio-facial/DiGeorge/22q11.2 deletion syndrome patients.

Authors:  Tingwei Guo; Donna McDonald-McGinn; Anna Blonska; Alan Shanske; Anne S Bassett; Eva Chow; Mark Bowser; Molly Sheridan; Frits Beemer; Koen Devriendt; Ann Swillen; Jeroen Breckpot; Maria C Digilio; Bruno Marino; Bruno Dallapiccola; Courtney Carpenter; Xin Zheng; Jacob Johnson; Jonathan Chung; Anne Marie Higgins; Nicole Philip; Tony J Simon; Karlene Coleman; Damian Heine-Suner; Jordi Rosell; Wendy Kates; Marcella Devoto; Elizabeth Goldmuntz; Elaine Zackai; Tao Wang; Robert Shprintzen; Beverly Emanuel; Bernice Morrow
Journal:  Hum Mutat       Date:  2011-09-16       Impact factor: 4.878

7.  Overt cleft palate phenotype and TBX1 genotype correlations in velo-cardio-facial/DiGeorge/22q11.2 deletion syndrome patients.

Authors:  Sean B Herman; Tingwei Guo; Donna M McDonald McGinn; Anna Blonska; Alan L Shanske; Anne S Bassett; Eva W C Chow; Mark Bowser; Molly Sheridan; Frits Beemer; Koen Devriendt; Ann Swillen; Jeroen Breckpot; M Cristina Digilio; Bruno Marino; Bruno Dallapiccola; Courtney Carpenter; Xin Zheng; Jacob Johnson; Jonathan Chung; Anne Marie Higgins; Nicole Philip; Tony Simon; Karlene Coleman; Damian Heine-Suner; Jordi Rosell; Wendy Kates; Marcella Devoto; Elaine Zackai; Tao Wang; Robert Shprintzen; Beverly S Emanuel; Bernice E Morrow
Journal:  Am J Med Genet A       Date:  2012-10-03       Impact factor: 2.802

Review 8.  22q11 deletion syndrome: a role for TBX1 in pharyngeal and cardiovascular development.

Authors:  Peter J Scambler
Journal:  Pediatr Cardiol       Date:  2010-04       Impact factor: 1.655

9.  Single nucleotide polymorphism discovery in TBX1 in individuals with and without 22q11.2 deletion syndrome.

Authors:  Carrie L Heike; Jacqueline R Starr; Mark J Rieder; Michael L Cunningham; Karen L Edwards; Ian B Stanaway; Dana C Crawford
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2010-01

Review 10.  When half is not enough: gene expression and dosage in the 22q11 deletion syndrome.

Authors:  D W Meechan; T M Maynard; D Gopalakrishna; Y Wu; A S LaMantia
Journal:  Gene Expr       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.